Evidence map›Paper›PMID 38302562›Full record

SynthesisMolecular psychiatry2024

On the proportion of patients who experience a prodrome prior to psychosis onset: A systematic review and meta-analysis.

David Benrimoh, Viktor Dlugunovych, Abigail C Wright, Peter Phalen, Melissa C Funaro, Maria Ferrara, Albert R Powers, Scott W Woods, Sinan Guloksuz, Alison R Yung and 2 more

Erratum issuedAbstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Molecular psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Clinical high-risk vs. population-level prevention of mental disorders: a false dichotomy.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2026
    Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Real-world comprehensive care of people living with schizophrenia: recommendations across different settings and clinical stages.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Repurposing medications to prevent psychosis.Npj mental health research · 2025
    Review
  18. Article
  19. Observational
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

David BenrimohPEPP-Montréal, Department of Psychiatry and Douglas Research Center, McGill University, Montreal, QC, Canada. david.benrimoh@mcgill.ca.ORCID 0000-0002-1452-4791
Viktor DlugunovychCreedmoor Psychiatric Center, New York, NY, USA.ORCID 0000-0002-8057-1721
Abigail C WrightCenter of Excellence for Psychosocial and Systemic Research, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0001-7046-2049
Peter PhalenDivision of Psychiatric Services Research, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-4219-3475
Melissa C FunaroHarvey Cushing/John Hay Whitney Medical Library, Yale University, New Haven, CT, USA.
Maria FerraraInstitute of Psychiatry, Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.
Albert R PowersYale University School of Medicine and the Connecticut Mental Health Center, New Haven, CT, USA.ORCID 0000-0003-3057-5043
Scott W WoodsYale University School of Medicine and the Connecticut Mental Health Center, New Haven, CT, USA.
Sinan GuloksuzSpecialized Treatment Early in Psychosis Program (STEP), Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-6626-1874
Alison R YungInstitute of Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Melbourne, Australia.ORCID 0000-0002-0401-9791
Vinod SrihariYale University School of Medicine and the Connecticut Mental Health Center, New Haven, CT, USA.ORCID 0000-0003-1556-2332
Jai ShahPEPP-Montréal, Department of Psychiatry and Douglas Research Center, McGill University, Montreal, QC, Canada.ORCID 0000-0002-7549-6990

Funding

STEP-ED:Reducing Duration of Untreated Psychosis and its Impact in the U.S.R01MH103831 · NIMH · YALE UNIVERSITY · PI SRIHARI, VINOD H. · 2013 to 2017
$3.9M
Targeting Emotion Dysregulation to Reduce Suicide in People with PsychosisK23MH125024 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI PHALEN, PETER LEE · 2022 to 2025
$711k
NIMH NIH HHS K23 MH125024NIMH NIH HHS R01 MH103831
6 · The paper itself

Abstract

backgroundPreventing or delaying the onset of psychosis requires identification of those at risk for developing psychosis. For predictive purposes, the prodrome - a constellation of symptoms which may occur before the onset of psychosis - has been increasingly recognized as having utility. However, it is unclear what proportion of patients experience a prodrome or how this varies based on the multiple definitions used.

methodsWe conducted a systematic review and meta-analysis of studies of patients with psychosis with the objective of determining the proportion of patients who experienced a prodrome prior to psychosis onset. Inclusion criteria included a consistent prodrome definition and reporting the proportion of patients who experienced a prodrome. We excluded studies of only patients with a prodrome or solely substance-induced psychosis, qualitative studies without prevalence data, conference abstracts, and case reports/case series. We searched Ovid MEDLINE, Embase (Ovid), APA PsycInfo (Ovid), Web of Science Core Collection (Clarivate), Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, APA PsycBooks (Ovid), ProQuest Dissertation & Thesis, on March 3, 2021. Studies were assessed for quality using the Critical Appraisal Checklist for Prevalence Studies. Narrative synthesis and proportion meta-analysis were used to estimate prodrome prevalence. I

resultsSeventy-one articles were included, representing 13,774 patients. Studies varied significantly in terms of methodology and prodrome definition used. The random effects proportion meta-analysis estimate for prodrome prevalence was 78.3% (95% CI = 72.8-83.2); heterogeneity was high (I

conclusionsThis is the first meta-analysis on the prevalence of a prodrome prior to the onset of first episode psychosis. The majority of patients (78.3%) were found to have experienced a prodrome prior to psychosis onset. However, findings are highly heterogenous across study and no definitive source of heterogeneity was found despite extensive subgroup analyses. As most studies were retrospective in nature, recall bias likely affects these results. While the large majority of patients with psychosis experience a prodrome in some form, it is unclear if the remainder of patients experience no prodrome, or if ascertainment methods employed in the studies were not sensitive to their experiences. Given widespread investment in indicated prevention of psychosis through prospective identification and intervention during the prodrome, a resolution of this question as well as a consensus definition of the prodrome is much needed in order to effectively direct and organize services, and may be accomplished through novel, densely sampled and phenotyped prospective cohort studies that aim for representative sampling across multiple settings.

Indexed as

Prodromal SymptomsPsychotic DisordersHumansPrevalence

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.